Evidence map›Paper›PMID 33875617›Full record

ArticleAging2021

MiR-27a-3p suppresses cerebral ischemia-reperfusion injury by targeting FOXO1.

Wenyu Li, Qiongbin Zhu, Xiaoyan Xu, Xingyue Hu

Open access · greenAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. MiR-27a-3p protects against NaAsOScientific reports · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. [mNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. miR-27a TargetingAnimals : an open access journal from MDPI · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wenyu LiDepartment of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 133000, Zhejiang, China.
Qiongbin ZhuDepartment of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 133000, Zhejiang, China.
Xiaoyan XuDepartment of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 133000, Zhejiang, China.
Xingyue HuDepartment of Neurology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 133000, Zhejiang, China.
Sir Run Run Shaw Hospital · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral ischemia-reperfusion (CI/R) injury is a serious complication when treating patients experiencing ischemic stroke. Although the microRNA miR-27a-3p reportedly participates in ischemia/reperfusion (I/R) injury, its actions in CI/R remain unclear. To mimic CI/R

Indexed as

AnimalsApoptosisBrainCell Cycle CheckpointsCell LineCyclin-Dependent Kinase Inhibitor p27Disease Models, AnimalDown-RegulationForkhead Box Protein O1HumansIschemic StrokeMiceMicroRNAsNerve Tissue ProteinsNeuronsOxidative StressCdkn1b protein, mouseCdkn1b protein, ratCyclin-Dependent Kinase Inhibitor p27Forkhead Box Protein O1Foxo1 protein, mouseFoxo1 protein, ratMicroRNAsMirn27 microRNA, mouseMIRN27 microRNA, ratNerve Tissue Proteinscell injuryCI/RFOXO1miR-27a-3p

Identifiers

PMID33875617
PMCPMC8109123
OpenAlexW3155733544

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.